Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%

MT Newswires Live

Sep 11, 2024

Genetic Technologies (ASX:GTG) joined the Chicago-based CancerIQ platform, giving it access to the US healthcare system, according to a Wednesday filing with the Australian bourse.

As part of the move, Genetic Technologies will pay an annual fee of $75,000 to access CancerIQ's premium tier, the filing stated. This will give the molecular diagnostics company an entry point to over 45 health systems and 250 clinics in the US that are part of CancerIQ's platform.

The partnership includes the addition of Genetic Technologies' geneType risk assessment test portfolio to support CancerIQ's expansion into primary preventive care.

Genetic Technologies' shares were up nearly 8% in recent trade.

Price (AUD): $0.04, Change: $+0.0030, Percent Change: +7.50%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2466444609"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2466444609\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2466444609?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-11 10:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466444609","market":"sh","top_or_hot":-1,"title":"Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%","media":"MT Newswires Live","content":"<html><body><p>Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%</p><p> Genetic Technologies (ASX:GTG) joined the Chicago-based CancerIQ platform, giving it access to the US healthcare system, according to a Wednesday filing with the Australian bourse.</p><p>As part of the move, Genetic Technologies will pay an annual fee of $75,000 to access CancerIQ's premium tier, the filing stated. This will give the molecular diagnostics company an entry point to over 45 health systems and 250 clinics in the US that are part of CancerIQ's platform.</p><p>The partnership includes the addition of Genetic Technologies' geneType risk assessment test portfolio to support CancerIQ's expansion into primary preventive care.</p><p>Genetic Technologies' shares were up nearly 8% in recent trade.</p><p>Price (AUD): $0.04, Change: $+0.0030, Percent Change: +7.50%</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-11 10:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8% Genetic Technologies (ASX:GTG) joined the Chicago-based CancerIQ platform, giving it access to the US healthcare system, according ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GTG.AU","symbol_name":"Genetic Technologies Ltd","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2466444609","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466444609","pubTimestamp":1726023273,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8% Genetic Technologies (ASX:GTG) j","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"GTG.AU":"Genetic Technologies Ltd","XJO.AU":"标普/澳交所 200指数","XAO.AU":"标普/澳交所 普通股指数","BK4121":"生命科学工具和服务","BK7508":"医药生物股","BK7048":"生命科学工具和服务","XKO.AU":"标普/澳交所 300指数","BK4125":"广播"},"translate_title":"Genetic Technologies加入总部位于美国的CancerIQ平台；股价上涨8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XAO.AU":1,"GTG.AU":1,"XJO.AU":1,"GENE":1,"XKO.AU":1,"AUD":1},"content_text":"Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8% Genetic Technologies (ASX:GTG) joined the Chicago-based CancerIQ platform, giving it access to the US healthcare system, according to a Wednesday filing with the Australian bourse.As part of the move, Genetic Technologies will pay an annual fee of $75,000 to access CancerIQ's premium tier, the filing stated. This will give the molecular diagnostics company an entry point to over 45 health systems and 250 clinics in the US that are part of CancerIQ's platform.The partnership includes the addition of Genetic Technologies' geneType risk assessment test portfolio to support CancerIQ's expansion into primary preventive care.Genetic Technologies' shares were up nearly 8% in recent trade.Price (AUD): $0.04, Change: $+0.0030, Percent Change: +7.50%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}